Publication Name	World Journal of Clinical Oncology
Manuscript ID	90615
Country	China

Received	2023-12-08 13:36
Peer-Review Started	2023-12-08 13:36
To Make the First Decision
Return for Revision	2023-12-18 09:24
Revised	2023-12-27 13:54
Second Decision	2024-02-25 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-02-25 06:03
Articles in Press	2024-02-25 06:03
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-02-22 14:16
Typeset the Manuscript	2024-03-08 06:57
Publish the Manuscript Online	2024-03-22 11:48

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cell Biology
Manuscript Type	Editorial
Article Title	Role of targeting ferroptosis as a component of combination therapy in combating drug resistance in colorectal cancer
Manuscript Source	Invited Manuscript
All Author List	Xiao-Ting Xie, Qiang-Hu Pang and Lian-Xiang Luo
Funding Agency and Grant Number
Corresponding Author	Lian-Xiang Luo, PhD, Associate Professor, The Marine Biomedical Research Institute, Guangdong Medical University, No. 2 Wenming East Road, Xiashan District, Zhanjiang 524023, Guangdong Province, China. lulianxiang321@gdmu.edu.cn
Key Words	Colorectal cancer; Ferroptosis; Immunotherapy; Drug resistance; Chemotherapy; Nanodrug delivery systems
Core Tip	Drug resistance poses a challenge to the treatment of colorectal cancer (CRC). In this paper, we offer novel perspectives on tackling this issue by focusing on ferroptosis in CRC cells. This approach holds promise in overcoming tumor cell resistance caused by CRC genome instability and changes in the tumor microenvironment, thereby providing innovative therapeutic strategies to break through the clinical drug resistance in CRC.
Publish Date	2024-03-22 11:48
Citation	Xie XT, Pang QH, Luo LX. Role of targeting ferroptosis as a component of combination therapy in combating drug resistance in colorectal cancer. World J Clin Oncol 2024; 15(3): 375-377
URL	https://www.wjgnet.com/2218-4333/full/v15/i3/375.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i3.375

Full Article (PDF)	WJCO-15-375-with-cover.pdf
Manuscript File	90615_Auto_Edited_WangTQ-HZ-YJP.docx
Answering Reviewers	90615-Answering reviewers.pdf
Audio Core Tip	90615-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90615-Conflict-of-interest statement.pdf
Copyright License Agreement	90615-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90615-Language certificate.pdf
Peer-review Report	90615-Peer-review(s).pdf
Scientific Editor Work List	90615-Scientific editor work list.pdf
CrossCheck Report	90615-CrossCheck report.pdf